Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Breast Cancer Research and Treatment|January 10, 2021
Spindle and kinetochore‑associated complex subunit 3 accelerates breast cancer cell proliferation and invasion through the regulation of Akt/Wnt/β-catenin signalingJian Zhang, Yang Liu, Shengyu Pu, et al.
Annals of Surgical Oncology|October 23, 2020
Can We Reliably Identify the Pathological Outcomes of Neoadjuvant Chemotherapy in Patients with Breast Cancer? Development and Validation of a Logistic Regression Nomogram Based on Preoperative FactorsJian Zhang, Linhai Xiao, Shengyu Pu, et al.
Journal of Oncology|September 28, 2021
Research on Effectiveness of Prior Cancer on Survival Outcomes for Patients with Nonmetastatic Triple-Negative Breast Cancer: A Competing Risk Analysis and Propensity Score Matching Analysis of the SEER DatabaseHeyan Chen, Lutong Yan, Shengyu Pu, et al.
Gland Surgery|July 16, 2021
A nomogram based on CENPP expression for survival prediction in breast cancerHeyan Chen, Shengyu Pu, Shibo Yu, et al.
Frontiers in Oncology|April 14, 2023
Evaluation of outcome of chemotherapy for breast cancer patients older than 70 years: A SEER-based studyShengyu Pu, Peiling Xie, Heyan Chen, et al.
Cancer Biomarkers : Section a of Disease Markers|November 14, 2022
Identification of prognostic biomarkers among ICAMs in the breast cancer microenvironmentHeyan Chen, Shengyu Pu, Nan Mei, et al.
Journal of Translational Medicine|March 26, 2025
ZBTB6 promotes breast cancer progression by inhibiting ARHGAP6 transcription and modulating the STAT3 signaling pathwayXiaojiang Tang, Chaowei Deng, Yang Liu, et al.
BMC Cancer|November 20, 2020
Nomogram-derived prediction of pathologic complete response (pCR) in breast cancer patients treated with neoadjuvant chemotherapy (NCT)Shengyu Pu, Ke Wang, Yang Liu, et al.
Frontiers in Oncology|July 11, 2022
A Novel Risk-Scoring System to Identify the Potential Population Benefiting From Adjuvant Chemotherapy for Node-Negative TNBC Patients With Tumor Size Less Than 1 cmYijun Li, Rulan Ma, Heyan Chen, et al.
Scientific Reports|July 3, 2023
A risk stratification model to predict chemotherapy benefit in medullary carcinoma of the breast: a population-based SEER databaseHeyan Chen, Shengyu Pu, Lizhao Wang, et al.
Pageof 3